Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: Cholangiocarcinoma (CCA) is a cancer of the biliary system, including intrahepatic and extrahepatic cholangiocarcinoma, and is highly aggressive. C-type lectins family member 3b (CLEC3B) is a Ca binding transmembrane protein with different biological functions in a variety of cancers. The objective of this study was to explore the biological function of CLEC3B in CCA.
Methods: The CLEC3B gene was identified using the TCGA database and survival analysis of the cholangiocarcinoma clinical cohort. The expression CLEC3B cholangiocarcinoma and correlation with prognosis was investigated in our patient cohort. The effects of CLEC3B on proliferation, apoptosis, migration and invasion were verified in QBC939 and HUCCT1 cells. The effect of CLEC3B on the tumor formation was proved by xenograft tumor model in nude mice. The signaling pathway of CLEC3B in regulating CCA progression was further analyzed RNA sequencing and western blot.
Results: CLEC3B was decreased in the cholangiocarcinoma in the database. The mRNA and protein expression level of CLEC3B were significantly lower and correlated with poor overall survival in cholangiocarcinoma of our patient cohort. experiments proved that overexpression of CLEC3B can inhibit proliferation, migration and invasion in bile duct cancer cells. The CLEC3B was correlated with epithelial-mesenchymal transition and apoptosis. The calcium could promote the biological function of CLEC3B. The vivo study indicated that CLEC3B inhibited tumor formation. RNA sequencing indicating CLEC3B may transduce signal through e Wnt/β-catenin signaling pathway.
Conclusions: The CLEC3B inhibits cellular proliferation and migration of cholangiocarcinoma through the Wnt/β-catenin pathway.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11568818 | PMC |
| http://dx.doi.org/10.7717/peerj.18497 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Estrogen Receptor-α Loss Accelerates Cartilage Degradation through CLEC3B-Mediated Chondrocyte Hypertrophy and Inflammation.
Osteoarthritis Cartilage
September 2025
Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Bioengineering, University of Pittsburgh Swanson School of Engineering, Pittsburgh, PA, USA; Orland Bethel Family Musculoskeletal Research Center, University of Pittsburgh School of Med
Objective: Previous studies in our lab demonstrated that estrogen receptor-α (ERα) levels in cartilage decreased with osteoarthritis (OA). We also defined the essential role of ERα in maintaining the health of chondrocytes. However, most of the studies were conducted in vitro, and the physiological link between ERα loss and cartilage degradation has not been demonstrated using animal models.
View Article and Find Full Text PDFC-type lectin domain family 3 member B (CLEC3B) inhibits triple-negative breast cancer chemoresistance via inducing ferroptosis.
Eur J Med Res
August 2025
Central Lab, Shenzhen Longhua Maternity and Child Healthcare Hospital, Shenzhen, 518110, China.
Background And Aims: Cisplatin is one of effect chemotherapeutic drugs for triple-negative breast cancer (TNBC). However, cisplatin chemoresistance often generate in a notable proportion of TNBC patients, leading therapeutic failure. Thus, identification of key regulatory mechanisms for chemoresistance is important.
View Article and Find Full Text PDFHigh-throughput DeepPRM-Stellar proteomics coupled with machine learning enables precise quantification of atherosclerosis-stroke progression biomarkers and risk prediction.
Analyst
August 2025
State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Fujian 361102, China.
Predicting the progression of asymptomatic large-artery atherosclerosis (LAA) to acute ischemic stroke (AIS) remains a significant challenge when relying solely on anatomical stenosis. To address this clinical gap, we integrated discovery-phase serum proteomics with machine-learning techniques to identify circulating biomarkers capable of predicting atherosclerotic progression. Utilizing a dual-cohort design (Cohort I: discovery stage, = 43; Cohort II: validation stage, = 39), we established a Serum Protein Candidate Biomarker Bank (SPCBB) encompassing 1484 proteins by harmonizing literature-derived evidence (1369 proteins) with 222 differentially expressed proteins (DEPs) identified through mass spectrometry analysis.
View Article and Find Full Text PDFCharacterization of T cell proliferation-associated hepatocellular carcinoma subtypes, predictive signatures, and candidate targets.
J Gastrointest Oncol
June 2025
Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Background: T cells are essential mediators of antitumor immune responses. While T cell proliferation-related genes (TRGs) have been identified, how they relate to prognostic outcomes in hepatocellular carcinoma (HCC) patients remains uncertain. This study attempts to analyze the relationship between TRGs and the prognosis of patients with HCC from multiple perspectives.
View Article and Find Full Text PDFThe mechanism of RNA methylation writing protein-related prognostic genes in lung adenocarcinoma based on bioinformatics.
Front Genet
June 2025
Good Clinical Practice Center, Guizhou Provincial People's Hospital, Guiyang, China.
Objective: RNA methylation modifications play biological roles in tumorigenicity and immune response, mainly mediated by the "writer" enzyme. Lung adenocarcinoma (LUAD) development is closely related to RNA methylation. Here, the prognostic values of the "writer" enzymes and the tumor immunosurveillance in LUAD aim to provide new theoretical references for the research of LUAD.
View Article and Find Full Text PDF